[Study of the analgesic effect of the semax preparation].
Koroleva
M V
MV
Meĭzerov
E E
EE
Nezavibat'ko
V N
VN
Kamenskiĭ
A A
AA
Dubynin
V A
VA
Iakovlev
Iu B
IuB
D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy* / Q000503:physiopathology; D010147:Pain Measurement / Q000187:drug effects; D017288:Pain Threshold / Q000187:drug effects; D010446:Peptide Fragments / Q000627:therapeutic use*; D014098:Toothache / Q000188:drug therapy* / Q000503:physiopathology
D018712:Analgesics, Non-Narcotic; D010446:Peptide Fragments; C048487:ACTH (4-7), Pro-Gly-Pro-; D000324:Adrenocorticotropic Hormone